- Home
- SVRA vs EMD Comparison
SVRA vs EMD Comparison
Compare SVRA & EMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- EMD
- Stock Information
- Founded
- SVRA 2007
- EMD 2003
- Country
- SVRA United States
- EMD United States
- Employees
- SVRA N/A
- EMD N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- EMD Finance/Investors Services
- Sector
- SVRA Health Care
- EMD Finance
- Exchange
- SVRA Nasdaq
- EMD Nasdaq
- Market Cap
- SVRA 505.8M
- EMD 527.7M
- IPO Year
- SVRA N/A
- EMD N/A
- Fundamental
- Price
- SVRA $3.00
- EMD $9.40
- Analyst Decision
- SVRA Buy
- EMD
- Analyst Count
- SVRA 6
- EMD 0
- Target Price
- SVRA $8.83
- EMD N/A
- AVG Volume (30 Days)
- SVRA 615.8K
- EMD 248.5K
- Earning Date
- SVRA 05-16-2025
- EMD 01-01-0001
- Dividend Yield
- SVRA N/A
- EMD 10.25%
- EPS Growth
- SVRA N/A
- EMD N/A
- EPS
- SVRA N/A
- EMD N/A
- Revenue
- SVRA N/A
- EMD N/A
- Revenue This Year
- SVRA N/A
- EMD N/A
- Revenue Next Year
- SVRA N/A
- EMD N/A
- P/E Ratio
- SVRA N/A
- EMD N/A
- Revenue Growth
- SVRA N/A
- EMD N/A
- 52 Week Low
- SVRA $2.26
- EMD $7.85
- 52 Week High
- SVRA $5.31
- EMD $9.55
- Technical
- Relative Strength Index (RSI)
- SVRA 47.98
- EMD 52.45
- Support Level
- SVRA $3.12
- EMD $9.35
- Resistance Level
- SVRA $3.56
- EMD $9.49
- Average True Range (ATR)
- SVRA 0.15
- EMD 0.11
- MACD
- SVRA -0.01
- EMD 0.05
- Stochastic Oscillator
- SVRA 21.19
- EMD 82.46
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About EMD Western Asset Emerging Markets Debt Fund Inc
Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management investment company. Its primary investment objective is to seek high current income and the secondary objective is to seek capital appreciation.